Adverse events associated with immune checkpoint blockade in patients with Cancer: a systematic review of case reports, PLOS ONE 29 juill, vol.11, issue.7, p.160221, 2016. ,
Renal effects of immune checkpoint inhibitors, Nephrol Dial Transplant 26 déc, p.382, 2016. ,
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors, Kidney Int sept, vol.90, issue.3, pp.638-685, 2016. ,
Anti-CTLA4 antibody-induced lupus nephritis, N Engl J Med, vol.9, issue.2, pp.211-213, 2009. ,
Nephrotic syndrome with Cancer immunotherapies: a report of 2 cases, Am J Kidney Dis, vol.70, issue.4, pp.581-586, 2017. ,
2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides, Arthritis Rheum janv, vol.65, issue.1, pp.1-11, 2013. ,
Kidney involvement in medium-and large-vessel vasculitis, J Nephrol août, vol.29, issue.4, pp.495-505, 2016. ,
Renal sarcoidosis presenting as acute kidney injury with granulomatous interstitial nephritis and Vasculitis, Am J Kidney Dis 1 févr, vol.59, issue.2, pp.303-311, 2012. ,
Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma, Medicine, issue.1, p.96, 2017. ,
Vasculitis associated with immune checkpoint inhibitors-a systematic review, Clin Rheumatol sept, vol.37, issue.9, pp.2579-84, 2018. ,
Drug-associated polymyalgia Rheumatica/Giant cell arteritis occurring in two patients after treatment with Ipilimumab, an antagonist of CTLA-4: concise communication, Arthritis Rheumatol mars, vol.66, issue.3, pp.768-777, 2014. ,
Association of Acute Interstitial Nephritis with Programmed Cell Death 1 inhibitor therapy in lung Cancer patients, Am J Kidney Dis août, vol.68, issue.2, pp.287-91, 2016. ,
Kidney injuries related to ipilimumab, Invest New Drugs août, vol.32, issue.4, pp.769-73, 2014. ,
Checkmate: kidney injury associated with targeted cancer immunotherapy, Kidney Int. sept, vol.90, issue.3, pp.474-480, 2016. ,
CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis, Rheumatology 1 déc, vol.48, issue.12, pp.1502-1507, 2009. ,
Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis, Clin Immunol juill, vol.128, issue.1, pp.39-45, 2008. ,
Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy, Semin Oncol, 2018. ,
,
, Publisher's Note
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations